OBJECTIVE: Leptin, an adipocyte-derived protein product of the obesity (ob) gene, is a multifunctional polypeptide associated with the development of obesity-related disorders in humans. There is considerable inter-individual variation in plasma leptin even among subjects with comparable obesity levels, which suggests that factors other than adipose mass may be involved in the regulation of leptin expression andaor production. The purpose of this study was to evaluate the potential role of glycemic status and adipose-derived cytokines in regulating plasma leptin levels among normal and overweight men. DESIGN: Cross-sectional study. SUBJECTS AND MEASUREMENTS: We measured plasma leptin, insulin, c-peptide and plasma soluble tumor necrosis factor receptor (sTNF-R) concentrations in 178 men. The subjects were selected from the Health Professionals Followup Study (HPFS), and aged 47 ± 64 y in 1994, were free of cardiovascular disease, diabetes mellitus, malignant neoplasms, and had provided a fasting blood sample and a detailed lifestyle questionnaire. RESULTS: Men in the highest quintile of plasma leptin (mean 12.7 ngaml) weighed more, were less physically active and had higher circulating insulin, c-peptide, sTNF-R1 and sTNF-R2 concentrations than men in the lowest quintile (mean 2.8 ngaml). We found a signi®cant correlation between plasma insulin, c-peptide, glycosylated hemoglobin (HbA1c), and sTNF-R1 on leptin concentrations (with Spearman correlation coef®cients ranging from 0.17 to 0.48 and all P`0.05). Only HbA1c and sTNF-R1 were independently and positively associated with plasma leptin after further adjusting for body mass index and other metabolic parameters of interest. Interestingly, these observed associations were limited to men with a BMI !25 kgam 2 . CONCLUSION: Our results suggest that glucose homeostasis and the activity of the TNF system may modulate leptin secretion and production among overweight men. Glucose homeostasis and TNF-a a is important in metabolic disorders related to hyperleptinemia.
Introduction
Leptin is a multifunctional polypeptide produced primarily by adipocytes and associated with the occurrence of obesity and insulin resistance in experimental models and humans. 1 ± 6 Leptin concentrations are highly correlated with the amount of body fat, body fat mass, percentage of body fat and body mass index at all ages. 7 ± 9 However, the wide variation in subjects with similar percentage body fat, 10 suggests that body fat may not be the only factor that regulates leptin concentrations. In fact, factors other than adiposity, such as cytokines, insulin and glucocorticoids, are reported to be directly involved in the regulation of leptin expression and production. 11 Experiments in cultured adipocytes and animal models have demonstrated that insulin stimulates leptin mRNA expression and increases circulating leptin concentrations. 12 ± 15 In humans, short-term insulin administration does not affect plasma leptin; 16 ± 21 however, prolonged insulin infusions result in elevation of plasma leptin concentrations. 2,16,22 ± 25 Cytokines are also involved in the regulation of leptin expression and production. 26, 27 Tumor necrosis factor (TNF), a polypeptide cytokine produced primarily by mononuclear phagocytes, plays a key role in the initiation of the in¯ammatory response, but has a multitude of effects in many tissues. 28 Biologically active human TNF-a may exist as either a membranebound (26 kDa) or soluble (17 kDa) protein. 29 TNF-a binds speci®cally to both cell-associated and soluble form receptors. 30 ± 32 Both the soluble receptors sTNF-R1 and sTNF-R2 are apparently derived by proteolytic cleavage from the cell surface receptors and can compete with the cell-associated receptors for TNF. 33, 34 Levels of these sTNF-Rs re¯ect the activation state of the TNF-a system. 33 TNF-a is also expressed in adipocytes in obesity and is capable of inhibiting insulin-stimulated glucose uptake by decreasing phosphorylation of the insulin receptor. 27, 35 Pharmacological or genetic blockade of TNF-a activity results in partial restoration of insulin receptor signaling and insulin sensitivity in obese, insulin resistant rats or mice. 35 ± 38 In humans, exogenous TNF-a injection and endogenous TNF-a concentration increase leptin concentrations in normal or diabetic subjects. 39, 40 These ®ndings suggest that TNF-a plays a signi®cant and important role in regulating leptin concentrations.
The interactions between insulin and TNF-a on leptin expression are complicated and have not been completely described. This may be due to the complex in¯u-ences of multiple biological parameters (such as age, gender, race, genetics, body fat mass, diurnal changes, glucose homeostasis and environmental effects such as dietary patterns and physical activity) on the expression and production of these hormones. 16,22 ± 25 A few previous studies examined the associations between glycemic status, TNF-a and leptin, but small sample size, 41, 42 unavailable measures of long term glycemic status, 40, 41 and minimal assessment of related lifestyle factors may limit these results.
The purpose of this study is to evaluate interactions between glycemic status and soluble TNF receptors (sTNF-R), as a marker of TNF-a activity, on circulating leptin concentrations among normal and overweight men. We hypothesize that plasma insulin and sTNF-R concentrations are associated with plasma leptin concentrations and that these associations may be modi®ed by factors that in¯uence long-term glucose homeostasis.
Materials and methods

The Health Professionals Follow-up Study
The Health Professionals Follow-up Study (HPFS) is a prospective study, designed primarily to investigate the association between diet and chronic disease among men. At baseline in 1986, 51,529 male US dentists, pharmacists, veterinarians, podiatrists and osteopathic physicians, who were 40 ± 75 y of age, completed a detailed questionnaire assessing diet, lifestyle characteristics and medical history. Every 2 y, participants have been recontacted to update exposure information and to ascertain newly diagnosed diseases. Between 1993 and 1995, 18,225 participants provided venous blood samples. The distributions of dietary and lifestyle characteristics were similar between the two populations who did and did not return a blood sample.
Research design
From the 18,225 men who returned a blood sample between 1993 and 1995, we excluded 8,922 men who did not complete questionnaire information on diet, cigarette smoking, alcohol consumption and physical activity from 1986 to 1994. We also excluded 208 men with cardiovascular disease, diabetes, gastric or duodenal ulcer, liver disease and cancer (except nonmelanoma skin cancer). From the remaining men, we randomly sampled 468 subjects (47 ± 83 y of age) based on seven clusters de®ned by their self-reported alcohol consumption pattern (eg abstain, light, moderate, binge, etc). For this analysis, we included only 268 men who provided a fasting sample (time since last meal before blood draw b6 h). In a sub-analysis, we further excluded 26 men who provided samples within 10 h after their last meal and found results were not substantially different. We excluded 91 men who were !65 y old since BMI may not be an adequate marker of fat mass among older men. The ®nal data set included 178 men aged 47 ± 64 y in 1994.
Exposure and outcome measurements
Anthropometric measurements. At baseline, each participant was asked to report his body height to the closest inch and on each biennial questionnaire his current weight in pounds. The validity of the selfreported anthropometric measures has been reported elsewhere. 43 We calculated body mass index (BMI) as the ratio of body weight to body height squared (kgam 2 ). In accordance with the new guidelines on obesity, 44 we de®ned overweight as a BMI !25 kgam 2 .
Lifestyle characteristics. Current smoking status was assessed at baseline and on each biennial follow-up questionnaire. Based on the subject's response to the 1994 answers, we subdivided subjects into four groups, never smokers, past smokers and current smokers (1 ± 14 and !15 cigarettes per day).
Alcohol intake was calculated by summing the frequency and amount of the alcoholic content of beer, red wine, white wine and spirits as reported by the participants on the semi-quantitative food-frequency questionnaire (SFFQ). The 1994 questionnaire contained questions on the average weekly time spent at four sedentary activities and 10 speci®ed leisure time physical activities during the past year. Metabolic equivalents for the task (METs) are de®ned for each type of physical activity as a multiple of the metabolic equivalent for sitting quietly for 1 h. Further
Associations of glycemic status, sTNF-R and leptin N-F Chu et al details on assessment and validation of self-reported physical activity measures and other lifestyle characteristics are reported elsewhere. 45, 46 Dietary information. Average total energy and total fat intake was derived from a SFFQ administered in 1994. The questionnaire has been evaluated in detail with regard to reproducibility and validity within the HPFS. 47 The correlation for nutrients estimated by the SFFQs and those measured by the 2 weeks of diet recording ranged from 0.37 for polyunsaturated fat to 0.92 for vitamin C with supplements (average 0.65) after adjusting for total energy and for within-person variation in intake.
Measurements of biochemical variables. To reduce extraneous between-person variation, we requested fasting blood samples. However, if the subjects were not fasting, a questionnaire requesting information on the date and time of the sample was drawn and the time elapsed since the preceding meal. Blood samples were collected in three 10 ml liquid EDTA blood tubes, placed on ice packs stored in styrofoam containers, and returned to the laboratory by overnight courier. More than 95% of samples arrived within 24 h after venipuncture. Upon arrival, each sample was centrifuged and aliquoted for storage in liquid nitrogen (À150 C). Fewer than 15% of samples were slightly hemolyzed, and very few were moderately hemolyzed (`3%), lipemic (`1%), or not cooled upon arrival (`0.5%). We found excellent stability of plasma leptin 48 and soluble tumor necrosis factor receptor (sTNF-R) levels (unpublished observations).
Plasma leptin concentrations were measured by radioimmunoassay (RIA), using a commercial kit (Linco Research, St Charles, MO) with antibody raised to highly puri®ed recombinant human leptin. 49 The inter-and intra-assay coef®cients of variation (CVs) in our assays were 3.4 ± 8.3%. Plasma insulin and c-peptide concentrations were determined by RIA (Linco Research, St Charles, MO) which allows accurate assessment with little or no cross-reactivity with proinsulin and each other, with a CV of`10%. In this study, we measured sTNF-R levels, as markers of TNF-a activity, by ELISA (R&D Systems, Minneapolis, MN for sTNF-R1 and Genzyme Diagnostics, Cambridge, MA for sTNF-R2), which permits accurate assessment with little or no TNF-a, TNF-b or other interleukin crossreactivity and a CV of`10%. Glycosylated hemoglobin (HbA1c) was measured as a marker of long-term glucose homeostasis by turbidometric immunoinhibition in red cells using the Hitachi 911 analyzer (Boehringer Mannheim). The CVs for HbA1c values of 5.6% and 9.6% were less than 2.5% and day-to-day variability for over a 1 y period at these two values was less than 5%.
Statistical analyses
Spearman correlation coef®cients between these metabolic variables were calculated to ensure validity of inference without assumptions of normality. Multivariate linear regression analyses were performed to evaluate the association of markers of glucose homeostasis and sTNF-R on plasma leptin concentrations. We conducted regression diagnostics to test assumptions of linearity and to determine the in¯uence of outliers. We present only the regression coef®cients from linear models since tests for non-linearity were not signi®cant. After excluding potential outliers ( AE 3Âinterquartile range of the 25th and 75th percentile of the leptin distribution) from the primary analyses, the results were not appreciably different from those presented below. All models controlled for age, cigarette smoking (never, past and current smoking of 1 ± 14 and !15 cigarettesaday), alcohol drinking (average alcohol intake gmaday), physical activity (average METsaweek), total energy intake (average kcaladay) and total fat intake (energy-adjusted gaday) and hours since last meal before blood draw (two categories, 6 ± 11 and !12 h). In separate models, we further adjusted for body mass index and other metabolic parameters to evaluate the independent association of these biological parameters with plasma leptin concentrations. Finally, we included a cross-product term (insulinÂsTNF-R1 or HbA1cÂsTNF-R1) to evaluate the interaction between these measures on leptin concentrations. For the multivariate linear regression models, we used the robust variance (using PROC MIXED in SAS) to insure validity of inference without the need to involve normal distribution assumptions. 50 We compared differences in age-adjusted anthropometric, dietary, lifestyle and biochemical characteristics across weight categories using one-way analysis of variance (ANOVA) for continuous variables and the w 2 test to assess associations between categorical variables.
Results
Characteristics of study subjects
At baseline, men in the highest quintile of plasma leptin (mean 12.7 ngaml) weighed more, were less physically active and had higher circulating insulin, cpeptide, sTNF-R1 and sTNF-R2 levels than men in the lowest quintile (mean 2.8 ngaml).
Correlation and regression models of plasma insulin and sTNF-R on leptin levels
The correlations between plasma leptin, insulin, cpeptide, HbA1c, sTNF-R1 and sTNF-R2 levels are shown in Table 1 . In general, plasma leptin level was positively correlated with sTNF-R1, HbA1c, insulin
To determine whether sTNF-R and glycemic parameters were independent predictors of leptin levels, we conducted multivariate linear regression models adjusting for age, cigarette smoking, alcohol drinking and physical activity. In separate multivariate models (Table 2 , model 1), insulin, HbA1c and sTNF-R1 were associated with leptin levels (all P`0.05). However, only HbA1c and sTNF-R1 levels were signi®cantly associated with plasma leptin after further adjusting for body mass index, insulin, cpeptide, and sTNF-R2 (Table 2 , model 2). Including interaction terms (insulinÂsTNF-R1 or HbA1cÂ sTNF-R1) did not signi®cantly change the ®t of the model or the signi®cant associations for insulin or sTNF-R1.
We next strati®ed our analyses by level of adiposity (BMI`25 kgam 2 and !25 kgam 2 ), since there may be marked differences in sensitivity to insulin and leptin among obese and non-obese individuals. Anthropometric, dietary, lifestyle and biochemical characteristics among normal and overweight men are presented in Table 3 . In general, overweight men were less physically active and had higher plasma leptin, insulin, c-peptide, and HbA1c levels than normal weight men.
Plasma leptin was positively correlated with insulin and c-peptide levels (with Spearman correlation coef®cients ranging from 0.22 to 0.36 and all P`0.05) in both normal and overweight men (Table 4 ). Among Table 1 Spearman correlation coef®cients between plasma leptin, insulin and soluble tumor necrosis factor receptor levels among 178 study subjects , glycosylated hemoglobin A1c; sTNF-R1 and sTNF-R2, soluble tumor necrosis factor receptor 1 and receptor 2. *P`0.05; **P`0.01; ***P`0.001.
Table 2
Multivariate regression models assessing plasma leptin concentrations by plasma insulin, sTNF-R and HbA1c levels among 178 subjects Ð leptin (ngaml) as dependent variable Model 1 includes age (y), cigarette smoking (never, past and current with 1 ± 14 and !15 cigarettesaday), alcohol drinking (average gaday), physical activity (average METsaweek), time of last meal before blood draw (two categories), total energy (caladay), and total fat intake (gaday). HbA1c, glycosylated hemoglobin A1c; sTNF-R1 and sTNF-R2, soluble tumor necrosis factor receptor 1 and receptor 2. *P`0.001 compared with normal weight group adjusted for age.
Table 4
Spearman correlation coef®cients between plasma leptin, insulin, sTNF-R and HbA1c levels among normal weight and overweight subjects HbA1c, glycosylated hemoglobin A1c; sTNF-R1 and sTNF-R2, soluble tumor necrosis factor receptor 1 and receptor 2. *P`0.05; **P`0.01; ***P`0.001.
Associations of glycemic status, sTNF-R and leptin N-F Chu et al overweight men (Table 5 ), HbA1c and sTNF-R1 were still signi®cantly positively associated with plasma leptin concentrations (both P`0.05). This association persisted even after adjustment for BMI and other metabolic parameters. However, among normal weight men, the insulinaglucose metabolic parameters and sTNF-R variables were not associated with plasma leptin concentrations.
Discussion
In this cross-sectional study of 47 ± 64-y-old men, we found a signi®cant positive association between HbA1c and sTNF-R1 and plasma leptin levels even after adjusting for body mass index and other metabolic parameters that might in¯uence leptin production. Interestingly, these observed associations were limited to men with a BMI !25 kgam 2 . These data suggest that the activity of TNF and long-term glucose homeostasis may modulate leptin concentrations among overweight men.
Although these data provide unique insights into associations between insulin, glucose homeostasis, TNF activity and leptin production in humans, the study does have some limitations. First, the study is cross-sectional, which prohibits us from making causal inferences. Second, biochemical indicators are ideal when they re¯ect long-term or cumulative exposure, 51 and a single assessment may be susceptible to substantial short term variation at least for some of the measures. However, in a sub-sample of 82 men from this population who provided blood sample 4 y apart, we have observed excellent intra-class correlations for leptin (0.74), HbA1c (0.73) and sTNF-R2 (0.78). Therefore, any error in leptin levels due to intra-individual variation or sample handling is likely to be small and random, which would bias our results towards the null. On the other hand, the intraclass correlation for insulin was somewhat lower (0.33) and might have limited our ability to determine the long-term effects of insulin on leptin levels. Finally, measurement error from using self-reported anthropometric measures, dietary intake and lifestyle characteristics is likely to be small 43, 45 and not appreciably bias our results because reporting error should not be associated with these biological markers.
We recognize that the HPFS cohort does not represent a random sample of US men. Therefore, patterns of diet and other lifestyle characteristics may not re¯ect those of the general population in the US. However, the homogeneity of the cohort with respect to educational attainment and socio-economic status reduces the likelihood that other extraneous unaccountable factors have biased our results. Because the ranges of the anthropometric parameters and the biological measures are quite broad and overlap with those previously reported in the general population, the associations we describe most likely are generalizable to all men of this age range.
In general, our results suggest that leptin may be associated with the modulation of insulin activity. The effects of leptin on glucose homeostasis are complicated. Leptin has been shown to inhibit tyrosine phosphorylation of the insulin receptor substrate-1 (IRS-1) and increase the activity of IRS-1 associated phosphatidylinositol 3-kinase. 57 In this way, leptin may play an important role in the etiology of hyperinsulinemia or insulin resistance. 3,25,52 ± 58 Other studies have shown bene®cial effects of leptin in vivo. The biology is even further complicated by the ®nding that insulin may also regulate leptin expression. 12 ± 15 Plasma leptin levels are decreased after fasting and increased by refeeding. 12, 23 In the fasting status, insulin injection can increase ob mRNA to levels of fed controls, 12,13 which suggests leptin mRNA expression is up-regulated by insulin. 59 However, leptin expression does not change after shortterm caloric restriction 19 and there is no acute insulin effect (either with euglycemic clamps, insulin injection or post-prandially) on ob gene mRNA expression or plasma leptin concentrations. 16 ± 21 Levels of leptin are increased by insulin only after prolonged administration; 2,12 a result consistent with our ®ndings that elevated HbA1c, and not c-peptide or insulin, is associated with higher leptin levels. Several previous studies in humans may not have found strong associations between glycemic status and leptin because the association may be modi®ed by other factors such as food intake, body fat mass and insulin sensitivity Table 5 Multivariate regression models assessing plasma leptin concentrations by plasma insulin, sTNF-R and HbA1c levels among normal weight and overweight subjects Ð leptin (ngaml) as dependent variable Associations of glycemic status, sTNF-R and leptin N-F Chu et al status. 22 ± 25 In our data, we did not ®nd a strong association for insulin or c-peptide since these measures may only provide a short-term`snap-shot' of glycemic status. The percentage of glycosylated hemoglobin A re¯ects a non-enzymatic reaction which is dependent on blood glucose level and the duration of exposure to elevated blood glucose. It may offer a better retrospective index of the mean blood glucose level over the preceding 1 ± 3 months, 60 and is a good marker of long-term hyperinsulinemia. Our results suggest that HbA1c only was an important predictor of leptin among overweight men who were presumably less sensitive to the effects of circulating insulin.
Besides insulin, cytokines also are involved the regulation of leptin expression and production. 27, 40, 61, 62 Cytokines primarily mediate the in¯am-matory host response to infection, 28 but also may regulate adipose tissue metabolism. 26, 38, 63 Although the interactions between insulin, the polypeptide cytokine TNF-a and leptin are complicated and not completely described in humans, it has been hypothesized that the TNF-a system may be involved in the development of insulin resistance and NIDDM, as well as regulate plasma leptin concentrations. 26,63 ± 65 In animals, exogenous TNF can produce a prompt and dose-dependent increase in serum leptin and leptin mRNA expression in a receptor dependent manner. 27, 61, 62 In parallel with this hypothesis, mice lacking TNF-a have lower leptin levels. 27, 66 However, obese TNF-a de®cient mice still have higher adipose tissue and circulating leptin levels than lean mice, which suggests that TNF-a is not the only regulator of adipose derived leptin. 27 In humans, TNF infusion results in increased leptin levels and plasma sTNF-R1 levels are positively and independently associated with leptin levels in normal and diabetic subjects. 39, 40 Adipose TNF-a mRNA expression increases with adiposity and decreases with weight loss. 63, 65 The activity of insulin and leptin may differ among normal weight and obese subjects, due to relative insulin andaor leptin resistance among obese individuals. 67, 68 In normal subjects, tightly regulated feedback mechanisms may lead to homeostasis between insulin, TNF-a and leptin. However, obese subjects with resistance to insulin and leptin may not respond to the feedback stimulation of insulin and leptin. Hence hyperinsulinemia or hyperleptinemia will develop. This may explain why elevated leptin was associated with weight gain among obese subjects in our population 69 and why associations of HbA1c and sTNF-R on leptin concentrations were limited to overweight subjects. Similar to our results, in a study of 42 obese subjects and 16 controls, Corica et al 41 found an association between leptin and sTNF-R1 in obese participants; however, they did not have a measure of long-term glycemic status. Further studies of glucose homeostasis and insulin sensitivity on leptin expression and production are indicated to investigate these complicated interactions.
In conclusion, we found that both sTNF-R1 and HbA1c were independently associated with plasma leptin concentrations among overweight men. Our results suggest that TNF-a and glucose homeostasis play signi®cant roles in leptin production. Further studies of leptin expression and production and factors that can modify leptin levels among normal weight and overweight individuals are necessary before the results from this analysis can be translated to strategies for preventing obesity and insulin resistance in humans.
